Alembic Pharma Gets 4 Observations From US FDA For Panelav Facility
Alembic Pharmaceuticals Ltd has received four observations from US Food and Drug Administration (FDA) for Panelav facility.The company stated that US FDA has conducted an inspection at it Panelav facility in Gujarat from 9-13 March, 2020"None of the observations are related to data integrity or repetitive in nature," the company added."The company will provide comprehensive corrective action report to address each observation. The company is committed to maintaining highest quality standards that meet US FDA standards," Alembic Pharma said in BSE filing.
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!